latest-news-headlines Market Intelligence /marketintelligence/en/news-insights/latest-news-headlines/omicron-variant-inflation-talk-put-damper-on-insurance-stocks-broader-market-67892785 content esgSubNav
In This List

Omicron variant, inflation talk put damper on insurance stocks, broader market


A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research


Street Talk Episode 87


A New Dawn for European Bank M&A Top 5 Trends


Insight Weekly: US banks' loan growth; record share buybacks; utility M&A outlook

Omicron variant, inflation talk put damper on insurance stocks, broader market

Insurance stocks moved lower this week, along with the wider market, as worries related to the COVID-19 omicron variant weighed on equities globally.

The S&P 500 Insurance index fell almost 2.5% on Nov. 30 as the variant spread from South Africa to North America. The first confirmed omicron case in the U.S. was recorded in California the following day. Stocks also reacted negatively after Moderna Inc. CEO Stéphane Bancel in an interview with the Financial Times said he expects a "material drop" in vaccine effectiveness against the variant.

Equities would manage to limit some of their losses, but the S&P 500 finished the week ending Dec. 3 down 1.22% at 4,538.43, while the S&P 500 Insurance index closed down 1.43% at 524.20.

SNL Image

Ed Moya, a senior analyst for OANDA, said Federal Reserve Chairman Jerome Powell also influenced markets this week when he said he supported a faster tapering of the Fed's bond-buying program and that inflation was no longer "transitory." Powell added that the risk of increased inflation had heightened and that the end of the central bank's low interest-rate policies was near.

Supply chain issues could intensify in the first quarter of 2022, Moya said, which could exacerbate inflation and send the Fed into "an accelerated rate-hiking cycle," raising fears of a recession.

"It was part Omicron and also part resetting of Fed rate-hike expectations that put some equities on a rollercoaster ride," Moya said in an interview. "I think we're probably going to have to deal with a new heightened uncertainty in both the virus and on inflation over these next few months."

Pricing pressures are not likely to ease up in the near future, Moya said. While equities are likely to move higher in 2022, "it's not going to be an easy ride" the way it has been since governments worldwide started providing historic fiscal and economic support due to the pandemic, he added.

Following a meeting with the senior management team from The Travelers Cos. Inc., Wells Fargo analyst Elyse Greenspan continues to have a positive view of the pricing and loss trend in the commercial market, but a more cautious view on the personal auto space. Travelers executives said the company's "historical" high retentions in the business insurance space indicates the current hard market still has "some legs," Greenspan said.

According to Greenspan, Travelers management also said personal auto frequency returned to pre-pandemic levels in the third quarter, while severity had risen by double digits.

Travelers finished the week down 2.93%, while The Allstate Corp., which announced it was selling its Northbrook, Ill., headquarters campus for $232 million, was down 5.91%. Lemonade Inc. tumbled 16.55%, and Erie Indemnity Company lost 12.37%.

In the managed care space, UnitedHealth Group Inc. executives said prior to the company's investor conference that it expects the impact of COVID-19 on 2022's earnings to be "about half" of what they saw this year.

The company expects 2021 net earnings of $17.80 to $17.95 per share and adjusted net earnings of $18.75 to $18.90 per share. For 2022, UnitedHealth anticipates net earnings of $20.20 to $20.70 per share and adjusted net earnings of $21.10 to $21.60 per share.

UnitedHealth was up 2.14% for the week. Major health insurers that finished in the red included Anthem Inc., down 4.94%, and Centene Corp., which lost 3.86%.